Abivax (ABVX) Operating Leases (2023 - 2025)

Abivax's Operating Leases history runs 3 years deep, the most recent figure standing at $1.1 million for Q3 2025.

• In Q3 2025, Operating Leases changed N/A year-over-year to $1.1 million; the TTM figure through Sep 2025 stood at $1.1 million (changed N/A YoY), while the FY2024 annual figure was $1.5 million, up 275.0% from the prior year.
• Operating Leases was $1.1 million for Q3 2025 at Abivax, down from $2.8 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $2.8 million in Q2 2025 to a low of $407781.2 in Q4 2023.
• Historically, Operating Leases has averaged $1.7 million across 3 years, with a median of $1.7 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Operating Leases jumped 275.0% in 2024, then soared 57.17% in 2025.
• A 3-year view of Operating Leases shows it stood at $407781.2 in 2023, then surged by 275.0% to $1.5 million in 2024, then slipped by 28.29% to $1.1 million in 2025.
• The last three Operating Leases figures came in at $1.1 million (Q3 2025), $2.8 million (Q2 2025), and $2.6 million (Q1 2025), per Business Quant data.